Teriak

Teriak, established in 1996, is a pharmaceutical laboratory headquartered in Tunisia. The company is dedicated to the development and export of pharmaceutical products, with a strong emphasis on quality as the cornerstone of its operations. Operating within the Healthcare and Pharmaceuticals sectors, Teriak focuses on delivering high-quality generic medications. Its strategic vision centers on achieving sustainable growth through robust international partnerships, particularly targeting markets in Africa and the Middle East. The company's commitment extends to enhancing its specialized expertise within the pharmaceutical industry.

With an employee range of 500 - 1,000 individuals, Teriak manages operations across 2 locations. The company prioritizes pharmacovigilance and fosters collaborative relationships with wholesalers to ensure efficient distribution and market penetration. Meet Teriak's team to understand the expertise driving its operational excellence and strategic initiatives. Teriak's business model is built on fostering long-term partnerships and maintaining stringent quality control throughout its product lifecycle, aiming to be a reliable supplier in its target regions.

Teriak generates an annual revenue of $17.5M, reflecting its established presence and market engagement. The company's B2B approach facilitates its expansion into new territories, leveraging its quality-focused product portfolio. By concentrating on international collaboration and adhering to high standards, Teriak is positioning itself for continued expansion and influence within the African and Middle Eastern pharmaceutical landscapes. Its founding year of 1996 signifies a long-standing commitment to the industry and its stakeholders.